← FDA DRUG APPROVALS

FDA ANDA · ANDA087211

METHOCARBAMOL AND ASPIRIN

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA087211
TYPE
ANDA
ORIGINAL APPROVAL
1982-12-22
LATEST ACTION
2002-07-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHOCARBAMOL AND ASPIRINDiscontinued
ASPIRIN 325MG, METHOCARBAMOL 400MG · TABLET · ORAL

Approval history

2002-07-29Manufacturing (CMC) · Supplement 30AP
2002-03-12Manufacturing (CMC) · Supplement 29AP
2001-03-07Manufacturing (CMC) · Supplement 26AP
2001-03-07Manufacturing (CMC) · Supplement 24AP
2001-03-07Manufacturing (CMC) · Supplement 27AP
2001-03-07Manufacturing (CMC) · Supplement 25AP
2001-01-19Manufacturing (CMC) · Supplement 23AP
2000-01-28Manufacturing (CMC) · Supplement 22AP
1999-11-23Manufacturing (CMC) · Supplement 21AP
1999-08-20Manufacturing (CMC) · Supplement 20AP
1998-12-09Manufacturing (CMC) · Supplement 19AP
1997-05-30Manufacturing (CMC) · Supplement 18AP
1992-12-17Manufacturing (CMC) · Supplement 16AP
1992-12-17Manufacturing (CMC) · Supplement 15AP
1988-09-14Manufacturing (CMC) · Supplement 11AP
1988-09-14Manufacturing (CMC) · Supplement 12AP
1988-09-14Manufacturing (CMC) · Supplement 10AP
1988-08-01Bioequivalence · Supplement 13AP
1987-07-20Manufacturing (CMC) · Supplement 6AP
1987-07-20Manufacturing (CMC) · Supplement 7AP
1984-03-16Manufacturing (CMC) · Supplement 4AP
1984-03-16Manufacturing (CMC) · Supplement 2AP
1983-07-13Manufacturing (CMC) · Supplement 1AP
1982-12-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →